Use of myocardial scar characterization to predict ventricular arrhythmia in cardiac resynchronization therapy

Europace

Volumn 14, Issue 11, 2012, Pages 1578-1586

  Fernández Armenta, Juan ^a   Berruezo, Antonio ^a   Mont, Lluis ^a   Sitges, Marta ^a   Andreu, David ^a   Silva, Etelvino ^a   Ortiz Pérez, Jose Tomás ^a   Tolosana, Jose María ^a   De Caralt, Teresa M ^b   Perea, Rosario Jesús ^b   Calvo, Naiara ^a   Trucco, Emilce ^a   Borràs, Roger ^a   Matas, María ^a   Brugada, Josep ^a  

^a L INSTITUT DU THORAX   (France)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Cardiac resynchronization therapy; Cardiomyopathy; Magnetic resonance imaging; Myocardial infarction; Sudden death; Ventricular tachycardia

Indexed keywords

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR MAGNETIC RESONANCE; CONTRAST ENHANCEMENT; FEMALE; FOLLOW UP; HEART MUSCLE INJURY; HEART MUSCLE SCAR; HEART VENTRICLE ARRHYTHMIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SUDDEN DEATH;

AGED; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; CARDIOMYOPATHY, DILATED; CHI-SQUARE DISTRIBUTION; CICATRIX; CONTRAST MEDIA; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FIBROSIS; GADOLINIUM DTPA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; KAPLAN-MEIER ESTIMATE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; TACHYCARDIA, VENTRICULAR; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84867526293     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eus104     Document Type: Article

References (26)

1. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-50.
2. Cleland JGF, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-49. (Pubitemid 40517094)
3. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJV, Ponikowski P, Poole-Wilson PA et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur J Heart Fail 2008;10:933-89.
4. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NAM III, Freedman RA, Gettes LS et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. J Am Coll Cardiol 2008;51:e1-62.
5. Dickstein K, Bogale N, Priori S, Auricchio A, Cleland JG, Gitt A et al. The European cardiac resynchronization therapy survey. Eur Heart J 2009;30:2450-60.
6. Saxon LA, Bristow MR, Boehmer J, Krueger S, Kass DA, De Marco T et al. Predictors of sudden cardiac death and appropriate shock in the comparison of medical therapy, pacing, and defibrillation in heart failure (COMPANION) trial. Circulation 2006;114:2766-72. (Pubitemid 46018278)
7. Yao G, Freemantle N, Calvert MJ, Bryan S, Daubert JC, Cleland JGF. The longterm cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator. Eur Heart J 2007;28:42-51. (Pubitemid 46134956)
8. Bello D, Fieno DS, Kim RJ, Pereles FS, Passman R, Song G et al. Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol 2005;45:1104-8. (Pubitemid 40432446)
9. Nazarian S, Bluemke DA, Lardo AC, Zviman MM, Watkins SP, Dickfeld TL et al. Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation 2005;112:2821-5. (Pubitemid 41641676)
10. Roes SD, Borleffs CJW, van der Geest RJ, Westenberg JJM, Marsan NA, Kaandorp TAM et al. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator. Circ Cardiovasc Imaging 2009; 2:183-90.
11. Yan AT, Shayne AJ, Brown KA, Gupta SN, Chan CW, Luu TM et al. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation 2006;114:32-9. (Pubitemid 44305272)
12. Schmidt A, Azevedo CF, Cheng A, Gupta SN, Bluemke DA, Foo TK et al. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation 2007;115:2006-14. (Pubitemid 46625951)
13. Heidary S, Patel H, Chung J, Yokota H, Gupta SN, Bennett MV et al. Quantitative tissue characterization of infarct core and border zone in patients with ischemic cardiomyopathy by magnetic resonance is associated with future cardiovascular events. J Am Coll Cardiol 2010;55:2762-8.
14. Mahrholdt H, Wagner A, Holly TA, Elliott MD, Bonow RO, Kim RJ et al. Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging. Circulation 2002;106:2322-7. (Pubitemid 35244732)
15. Cygankiewicz I, Gillespie J, Zareba W, Brown MW, Goldenberg I, Klein H et al. Predictors of long-term mortality in Multicenter Automatic Defibrillator Implantation Trial II (MADIT II) patients with implantable cardioverter- defibrillators. Heart Rhythm 2009;6:468-73.
16. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-53.
17. McCrohon JA, Moon JCC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJS et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003;108:54-59. (Pubitemid 36859020)
18. Mahrholdt H,Wagner A, Judd RM, Sechtem U, Kim RJ. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 2005;26:1461-74. (Pubitemid 41373486)
19. Moon JC, Reed E, Sheppard MN, Elkington AG, Ho SY, Burke M et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 2004;43:2260-4. (Pubitemid 38757595)
20. Bello D, Shah DJ, Farah GM, Di Luzio S, Parker M, Johnson MR et al. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation 2003;108:1945-53. (Pubitemid 37296539)
21. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ. Visualisation of presence, location and transmural extent of healed q-wave and non-q-wave myocardial infarction. Lancet 2001;357:21-8. (Pubitemid 32056497)
22. Hsia HH, Callans DJ, Marchlinski FE. Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia. Circulation 2003;108:704-10. (Pubitemid 36999255)
23. Nakahara S, Tung R, Ramirez RJ, Michowitz Y, Vaseghi M, Buch E et al. Characterization of the arrhythmogenic substrate in ischemic and nonischemic cardiomyopathy: implications for catheter ablation of hemodynamically unstable ventricular tachycardia. J Am Coll Cardiol 2010;55:2355-65.
24. Wu KC, Weiss RG, Thiemann DR, Kitagawa K, Schmidt A, Dalal D et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol 2008;51: 2414-21. (Pubitemid 351826874)
25. Assomull RG, Prasad SK, Lyne J, Smith G, Burman ED, Khan M et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006;48:1977-85. (Pubitemid 44738448)
26. Bleeker GB, Kaandorp TAM, Lamb HJ, Boersma E, Steendijk P, de Roos A et al. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation 2006;113:969-76. (Pubitemid 43879472)